Role of Blood Plasma Transfusion Against COVID-19
- Authors: Muhammad Ibrar1, Abdullah2, Iyad Ibrahim Shaqura3, Ahmed Abdelmajed Alkhodary4, Fazlullah Khan5
-
View Affiliations Hide Affiliations1 Department of Allied Health Sciences, Iqra National University Peshawar, Swat Campus, KP, Pakistan 2 Department of Pharmacy, University of Malakand, Chakdara Dir Lower, KP, Pakistan 3 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 4 Ministry of Health, Gaza Governorates, Palestinian Territory, Occupied 5 Department of Allied Health Sciences, Bashir Institute of Health Sciences, Bharakahu, Islamabad, Pakistan
- Source: Coronavirus Disease-19 (COVID-19): Different Models and Treatment Strategies , pp 253-265
- Publication Date: October 2021
- Language: English
Role of Blood Plasma Transfusion Against COVID-19, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681089072/chapter-10-1.gif
Historically, convalescent plasma (CP) has been successfully used in pandemics caused by the influenza A (H1N1) virus, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Ebola. As the current pandemic by SARS-CoV-2 poses an unprecedented threat to humanity. The number of infections is increasing exponentially day by day. Identifying, qualifying, collecting, and preparing plasma from convalescents with sufficient SARS-CoV-2 neutralizing antibody titers in this pandemic may be challenging but within the approach of most blood establishments. Careful clinical evaluation may rapidly establish whether CP therapy at the early onset of disease in patients of high risk may improve symptoms, reduce hospital stay and decrease mortality due to COVID-19. Moreover, CP is an excellent therapeutic option due to the lack of specific treatment for COVID-19, as the availability of anti-viral drugs/vaccines may take more time.
-
From This Site
/content/books/9781681089072.chapter-10dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
